Ventria Wins $4.2M Gates Foundation Grant toward Biomanufacturing ETEC Therapeutics

Ventria Bioscience said today it has won a $4.2 million grant from the Bill & Melinda Gates Foundation toward the biomanufacturing of new therapeutics targeting enterotoxigenic Escherichia coli (ETEC).Ventria said the grant will enable it to develop its ExpressTec technology platform for producing potential ETEC treatments.“This initiative aims to develop a new kind of oral treatment that could be delivered economically on a large scale for use in children or adults,” Ventria pre